Soegiharto R, Alizadeh Aghdam M, Sorensen JA, van Lindonk E, et al. Omalizumab is effective and safe in chronic inducible urticaria (CIndU): Real-world data from a large multi-national UCARE study. Allergy 2025;80:489-499.
PMID: 39377745